• The pandemic and lockdowns threaten the supply of medicines, especially from India
• Poor countries relying on supplies of cheap Indian medicines are especially vulnerable
• New medicines and vaccines are likely to be developed and patented by Western companies and will be expensive.
• Norway should help fund the supply of medicines and promote reforms of patent rules to make medicines more affordable
• Poor countries relying on supplies of cheap Indian medicines are especially vulnerable
• New medicines and vaccines are likely to be developed and patented by Western companies and will be expensive.
• Norway should help fund the supply of medicines and promote reforms of patent rules to make medicines more affordable
- Published year: 2020
-
Full version:
COVID-19_BRIEF_4_Eriksen.pdf (1,3 MB)
- Publisher: Norwegian Institute of International Affairs
- Page count: 5
- Language: English
- Journal: NUPI Covid-19 Brief